Drug Shortage Report for GANCICLOVIR FOR INJECTION
| Report ID | 163499 |
| Drug Identification Number | 02404761 |
| Brand name | GANCICLOVIR FOR INJECTION |
| Common or Proper name | GANCICLOVIR FOR INJECTION |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | GANCICLOVIR |
| Strength(s) | 500MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 10 ML |
| ATC code | J05AB |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2022-07-01 |
| Actual start date | 2022-07-01 |
| Estimated end date | 2022-07-22 |
| Actual end date | 2022-07-15 |
| Shortage status | Resolved |
| Updated date | 2022-07-16 |
| Company comments | Fresenius Kabi Canada regrets to advise that due to production and shipping delays, we will be encountering a supply interruption on our Ganciclovir for Injection 500 mg SD Vial 10 mL effective July 1, 2022 until July 22, 2022. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2022-07-16 | English | Compare |
| v5 | 2022-07-15 | French | Compare |
| v4 | 2022-07-15 | English | Compare |
| v3 | 2022-07-02 | English | Compare |
| v2 | 2022-06-27 | French | Compare |
| v1 | 2022-06-27 | English | Compare |
Showing 1 to 6 of 6